top of page
it's where dermatology lives
by John Evans
Jun 13, 20184 min read
New IL-23-targeted biologic approved in Canada for Tx of plaque psoriasis
Guselkumab, a biologic therapy that is part of a new class of agents targeting interleukin (IL)-23 without blocking IL-12, was approved...
by Louise Gagnon
Feb 20, 20184 min read
Additional therapies for hidradenitis suppurativa under investigation
HS delay in Dx a worldwide problem leading to complications
Featured Posts
bottom of page